Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease

Hosseini, Seyed Ahmad; Alipour, Meysam; Sarvandian, Sara; Haghighat, Neda; Bazyar, Hadi; Aghakhani, Ladan

doi:10.1186/s12902-024-01615-3

Table 2 Pearson’s correlation coefficients between anthropometric indices and hepatic and cardio-metabolic indices among males and females

From: Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease

Variables		WC	BMI	WHR	WHtR	BAI	VAI	WWI	CI	BRI	RFM	AVI
FBS	r	0.279	0.140	0.177	-0.173	0.166	0.158	0.149	0.166	0.176	0.115	0.180
FBS	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
MAP	r	0.162	0.136	0.099	-0.103	0.068	0.076	0.011	0.066	0.095	-0.054	0.158
MAP	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.337	< 0.001	< 0.001	< 0.001	< 0.001
AAR	r	-0.212	-0.191	-0.097	0.113	-0.045	-0.124	0.075	-0.017	-0.088	0.117	-0.200
AAR	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
ANI	r	-0.479	-0.533	-0.602	0.598	-0.623	-0.100	-0.442	-0.348	-0.595	-0.683	-0.478
ANI	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
HIS	r	0.817	0.903	0.777	-0770	0.722	0.186	0.284	0306	0.770	0.500	0.813
HIS	P	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
AIP	r	0.221	0.171	0.106	-0.126	0.054	0.813	-0.027	0.073	0.095	-0.102	0.205
AIP	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
LAP	r	0.533	0.458	0.472	-0.474	0.423	0.861	0.287	0.359	0.464	0.276	0.527
LAP	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
CMI	r	0.251	0.210	0.177	-0.188	0.138	0.965	0.058	0.125	0.169	0.007	0.242
CMI	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.534	< 0.001
LCI	r	0.133	0.096	0.086	-0.100	0.063	0.499	0.034	0.079	0.078	-0.030	0.122
LCI	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.003	< 0.001	< 0.001	0.007	< 0.001
TyG Index	r	0.271	0.216	0.190	-0.208	0.148	0.766	0.074	0.151	0.179	0.005	0.256
TyG Index	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.637	< 0.001
TyG-BMI	r	0.866	0.955	0.823	-0.808	0.765	0.365	0.304	0.330	0.820	0.507	0.865
TyG-BMI	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
TyG-WC	r	0.916	0.799	0.813	-0.808	0.730	0.491	0.481	0.602	0.804	0.464	0.908
TyG-WC	p	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
TIMI risk index	r	0.034	-0.118	0.102	-0.091	0.125	-0.014	0.349	0.341	0.105	0.095	0.036
TIMI risk index	p	0.003	< 0.001	< 0.001	< 0.001	< 0.001	0.229	< 0.001	< 0.001	< 0.001	< 0.001	0.001
CRI	r	0.161	0.115	0.066	-0.084	0.024	0.669	-0.029	0.054	0.056	-0.116	0.147
CRI	p	< 0.001	< 0.001	< 0.001	< 0.001	0.034	< 0.001	0.011	< 0.001	< 0.001	< 0.001	< 0.001
AI	r	0.112	0.076	0.056	-0.067	0.030	0.123	0.003	0.056	0.049	-0.069	0.101
AI	p	< 0.001	< 0.001	< 0.001	< 0.001	0.007	< 0.001	0.777	< 0.001	< 0.001	< 0.001	< 0.001

FBS Fasting blood pressure, MAP Mean Arterial Pressure, ANI; ALD/NAFLD Index, HIS Hepatic steatosis index, AIP Atherogenic index of plasma, LAP; CMI Cardiometabolic index, LCI The lipoprotein combine index, AI Atherogenic index, TyG The triglyceride-glucose

Back to article page

ISSN: 1472-6823

Contact us

General enquiries: journalsubmissions@springernature.com

BMC Endocrine Disorders

Contact us